PRA Completes Acquisition of Aktiv Kapital New 'PRA

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
PRA Completes Acquisition of Aktiv Kapital

New 'PRA Group' of Companies Expected to Create Value for Global Creditors

Expands 'Insolvency Investment Services' With Pamplona's IVA Platform

NORFOLK, Va., July 16, 2014 (GLOBE NEWSWIRE) -- Portfolio Recovery Associates, Inc. (Nasdaq: PRAA ) has completed its acquisition of Aktiv Kapital AS, a Norway-based leader in acquiring and servicing non-performing consumer debt throughout Europe and Canada. Effective today, the combined companies will be known as PRA Group, signaling to investors and global debt sellers PRA's plans for international growth from a group of companies across countries and regions.

PRA also has completed its acquisition of Pamplona Capital Management's Individual Voluntary Arrangements (IVA) Master Servicing Platform and other operating assets in the U.K., expanding PRA's ability to offer comprehensive debt buying solutions to global clients across a variety of their defaulted customer accounts.

"Leading banks and other creditors in Europe and Canada see value in a well-capitalized buyer of non-performing debt with a strong brand and reputation for compliance, able to purchase substantial portfolios on a regular basis," said Steve Fredrickson, chairman, president and chief executive officer, PRA Group. "We plan to leverage unique technology, data analytics and more than 20 years of experience in multiple countries, regions and cultures for the benefit of global banks, creditors, their customers and our shareholders."

In Europe and Canada, customers will continue to see the familiar Aktiv Kapital name. In the U.S. and U.K., customers will still interact with Portfolio Recovery Associates. PRA will continue to provide high-value contingency collection services to its existing U.K. clients in the financial services, retail, telecom, and utility industries.

PRA has appointed Geir Olsen, chief executive officer and board member of Aktiv Kapital, as chief executive officer of PRA Group Europe, which includes all of Aktiv Kapital's European operations and PRA's existing operations in the U.K. His management team and staff from Aktiv Kapital Europe and PRA UK's management team and staff will report to Olsen.

Pamplona's Andrew Berardi has been appointed Managing Director – UK, Insolvency Investment Services, PRA Group. His team of six people from Pamplona's U.K. IVA business also has joined PRA. IVAs are a formal alternative for U.K. consumers to primarily avoid bankruptcy. PRA's global Bankruptcy Services business also has been renamed Insolvency Investment Services effective today.

PRA will further discuss its acquisitions in Europe as the company exits its current quiet period upon announcing second quarter 2014 results after market close on August 5.

About PRA Group

Portfolio Recovery Associates, Inc., doing business as PRA Group, is a world leader in acquiring non-performing consumer debt. The companies of PRA Group return capital to global banks and other creditors to help expand financial services for consumers in North America and Europe. PRA Group companies collaborate with customers to create affordable, realistic debt repayment plans and provide a broad range of additional revenue and recovery services to business and government clients.

In 2013 and 2012, PRA was named one of Fortune's 100 Fastest-Growing Companies and one of Forbes' Top 25 Best Small Companies in America. PRA has been annually ranked on the Forbes list since 2007. PRA employs more than 4,000 people and is headquartered in Norfolk, Virginia. For more information, please visit www.pragroup.com .

About Forward Looking Statements

Statements made herein which are not historical, including PRA Group's or its management's intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future, including, but not limited to, statements with respect to future revenue, earnings per share growth and return on equity, and statements with respect to future contributions of Aktiv Kapital; the ability of Aktiv Kapital, or of any of PRA's subsidiaries, to contribute to earnings and future portfolio-purchase opportunities, all of which, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

The forward-looking statements in this press release are based upon management's beliefs, assumptions and expectations of PRA's future operations and economic performance, taking into account currently available information. These statements are not statements of historical fact and there can be no assurance that we will achieve our targets. Forward-looking statements involve risks and uncertainties, some of which are not currently known to PRA.

Actual events or results may differ materially from those expressed or implied in any such forward-looking statements as a result of various factors, including our ability to successfully integrate the Aktiv Kapital business or fully realize the expected benefits of the acquisition of Aktiv Kapital; our ability to manage risks associated with our international operations, which risks will increase as a result of the Aktiv Kapital acquisition; our ability to realize the anticipated synergies and benefits of the Aktiv acquisition; a prolonged economic recovery or a deterioration in the economic or inflationary environment in the United States or Europe; changes in, or interpretations of, state or federal laws or the administrative practices of various bankruptcy courts, which may impact our ability to collect on our defaulted receivables; governmental investigations into or enforcement actions against our business practices; our ability to employ and retain qualified employees; the degree, nature, and resources of our competition; changes in interest or exchange rates; and the risk factors and other risks that are described from time to time in PRA's filings with the Securities and Exchange Commission including but not limited to PRA's annual reports on Form 10-K, its quarterly reports on Form 10-Q and its current reports on Form 8-K, filed with the Securities and Exchange Commission and available through PRA's website, which contain detailed discussion of PRA's business, including risks and uncertainties that may affect future results.

Due to such uncertainties and risks, you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of today. Information in this press release may be superseded by recent information or statements, which may be disclosed in later press releases, subsequent filings with the Securities and Exchange Commission or otherwise. Except as required by law, PRA assumes no obligation to publicly update or revise its forward-looking statements contained herein to reflect any change in PRA's expectations with regard thereto or to reflect any change in events, conditions or circumstances on which any such forward-looking statements are based, in whole or in part.

Investor Contact: Darby Schoenfeld Director of Investor Relations (757) 431-7913 News Media Contact: Rick Goulart Vice President, Corporate Communications (757) 961-3525

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 637

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 202

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 345

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 60

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 203

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 356

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 215

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 107

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 42

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Li Auto Inc. Reports Record Revenue and Milestone Deliveries

Updated Category News Views 89

Li Auto Inc. Announces Impressive Financial Results In the latest quarter, Li Auto Inc. reported a remarkable total revenue of RMB42.9 billion (approximately US$6.1 billion), showcasing a year-over-year growth of 23.6%. This impressive performance reflects the company's strong market presence and strategic execution. Quarterly Deliveries and Growth In terms of vehicle...

Continue Reading
LifeWallet's $2 Million Settlement and Strategic Progress Ahead

Updated Category News Views 162

LifeWallet's Recent Settlement Progress LifeWallet, formerly known as MSP Recovery, has recently made headlines by announcing a preliminary $2 million settlement as part of its portfolio of pharmaceutical litigation cases. This development is just one part of the company's broader strategy to engage various pharmaceutical and medical device manufacturers. The commitment...

Continue Reading
Revolutionary Approaches to Managing Resistant Hypertension

Updated Category News Views 261

Understanding Resistant Hypertension Resistant hypertension is a significant challenge for many patients, often referred to as the silent killer due to its insidious nature. Many individuals suffering from high blood pressure are unaware they have it, leading to severe health complications like cardiovascular disease over time. With the upcoming World Hypertension Day,...

Continue Reading
Understanding Wipro's Anticipated Earnings Performance

Updated Category News Views 51

Understanding Wipro's Anticipated Earnings Performance Wipro (WIT) is poised to release its latest quarterly earnings shortly. Investors are eager to gain insights from this upcoming report, which is shaping up to be a pivotal moment for the company. With analysts estimating an earnings per share (EPS) of $0.07, stakeholders are closely watching for news that could...

Continue Reading
Breakthrough Gene Therapy for Parkinson's Secures FDA Designation

Updated Category News Views 276

Significant FDA Recognition for AB-1005 AskBio Inc., known for its groundbreaking work in gene therapy, has made headlines with the announcement that its investigational gene therapy AB-1005 has received the esteemed Regenerative Medicine Advanced Therapy (RMAT) designation from the United States Food and Drug Administration (FDA). This acknowledgement comes on the heels...

Continue Reading